Highlights from ASCO 2025—advances in the treatment of ovarian cancer
Summary Recent data presented at ASCO 2025 highlighted important advances in the treatment of ovarian cancer. The results of three key studies—TRUST, FIRST, and ROSELLA—provide new insights into optimal surgical strategies, the emerging role of immunotherapy, and novel systemic treatment options for platinum-resistant disease. This review summarizes these findings and discusses their potential impact on clinical practice.
Authors
- Stephan Polterauer (ORCID: https://orcid.org/0000-0002-9649-4505)
Institutions
- Medical University of Vienna (AT)
Publication Details
- Journal
- memo - Magazine of European Medical Oncology
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1007/s12254-025-01073-0
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Universität Wien
- Medizinische Universität Wien